On April 30, 2024, the Associated Press (AP) reported the Drug Enforcement Administration (DEA) will propose a rule to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). More...more
5/14/2024
/ Administrative Procedure Act ,
Biden Administration ,
Cannabis Products ,
Controlled Substances ,
Controlled Substances Act ,
DEA ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Final Rules ,
Food and Drug Administration (FDA) ,
IRS ,
Judicial Review ,
Marijuana ,
Medical Marijuana ,
Notice and Comment ,
NPRM ,
OMB ,
Popular ,
Regulatory Reform ,
Schedule I Drugs
Virginia’s HSA 1 Pharmaceutical Processor Permit -
Effective January 1, 2024, the Virginia Cannabis Control Authority (CCA) assumed regulatory oversight of Virginia’s medical cannabis program. The CCA was established in...more
With more than $10 million in retail sales during its opening weekend and more than $20 million in retail sales during the first week, Maryland’s adult-use cannabis market is open for business. Nearly 100 of Maryland’s...more
7/19/2023
/ Business Licenses ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Dispensaries ,
Legislative Agendas ,
Licensing Rules ,
Marijuana ,
Marijuana Cultivation ,
Marijuana Related Businesses ,
Medical Marijuana ,
State and Local Government
Last week the Maryland Cannabis Administration (MSA) released its draft emergency regulations for the state’s adult-use marijuana market which is set to come online on July 1. The draft regulations are subject to review by...more
5/31/2023
/ Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Dispensaries ,
Legislative Agendas ,
Licenses ,
Marijuana ,
Marijuana Related Businesses ,
Maryland ,
Medical Marijuana ,
New Legislation ,
Proposed Legislation ,
Regulatory Authority ,
State and Local Government
Significant changes to DC’s medical cannabis program are currently unfolding after the Medical Cannabis Amendment Act of 2022 (MCA) went into effect last month. Previously, DC’s medical cannabis program licensed dispensaries,...more
Maryland House Bill 556 (cross-filed with Maryland Senate Bill 516), introduced on February 3, 2023, contains essential provisions for any person or entity interested in participating in the cannabis industry in Maryland....more
3/15/2023
/ Agribusiness ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Clinical Laboratory Testing ,
Legislative Agendas ,
Licenses ,
Marijuana ,
Marijuana Related Businesses ,
Maryland ,
Medical Marijuana ,
New Legislation ,
Proposed Legislation ,
Regulatory Authority ,
Social Equity Programs ,
State and Local Government ,
Testing Requirements
Medical Cannabis in the DMV Continuing this year’s trend of increased access to legal cannabis in the Maryland, DC and Virginia area that started with Maryland adding legalization to the ballot in November, DC and Virginia...more
7/12/2022
/ Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Decriminalization of Marijuana ,
Dispensaries ,
Legislative Agendas ,
Marijuana ,
Marijuana Related Businesses ,
Medical Marijuana ,
New Legislation ,
Pharmaceutical Industry ,
State and Local Government